Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.116060 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Eleonora Cristarella und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy. Hauptthemen laut MEDLINE: Paclitaxel, Antineoplastic Combined Chemotherapy Protocols, Stomach Neoplasms, Esophageal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Italy.
- Department of Oncology, University of Turin, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
- Department of Oncology, Veneto Institute of Oncology Istituto Oncologico Veneto - IRCCS, Padua, Italy.
- Division of Medical Oncology, Department of Precision Medicine, University of Campania "L Vanvitelli", Naples, Italy.
- Medical Oncology Department ASL Toscana Centro, Santo Stefano Hospital, Prato, Italy.
- Oncology Unit, Careggi University Hospital, Florence, Italy.
Zitieren
APA
Cristarella, E., Ambrosini, M., Di Maio, M., Lonardi, S., De Vita, F., Di Donato, S., Giommoni, E., Spallanzani, A., Bittoni, A., Chini, C., Strippoli, A., Latiano, T. P., Brunetti, O., Tamberi, S., Cardellino, G. G., Spada, D., Fornaro, L., Alessandrini, S., Pietrantonio, F., & Randon, G. (2025). Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.116060
Vancouver
Cristarella E, Ambrosini M, Di Maio M, Lonardi S, De Vita F, Di Donato S, et al. Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.116060
BibTeX
@article{Cristarella2025,
author = {Cristarella, Eleonora and Ambrosini, Margherita and Di Maio, Massimo and Lonardi, Sara and De Vita, Ferdinando and Di Donato, Samantha and Giommoni, Elisa and Spallanzani, Andrea and Bittoni, Alessandro and Chini, Claudio and Strippoli, Antonia and Latiano, Tiziana Pia and Brunetti, Oronzo and Tamberi, Stefano and Cardellino, Giovanni Gerardo and Spada, Daniele and Fornaro, Lorenzo and Alessandrini, Sara and Pietrantonio, Filippo and Randon, Giovanni},
title = {Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.116060}
}
EUVIMED